Skip to main content
    B

    bioAffinity Technologies, Inc. (BIAF)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $2.00
    -0.20 (-9.09%)

    Market Cap: $4.00M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    bioAffinity Technologies, Inc. (BIAF) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    bioAffinity Technologies (BIAF) is expected to report earnings on Mar 11, 2027. In the quarter ended Sep 30, 2026, bioAffinity Technologies reported EPS of -$3.94. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    8%(1/12)
    Avg Surprise
    -24.63%

    Next Report

    BIAF has an expected report date of Mar 11, 2027.

    Earnings History

    Of the 12 quarters below that had an estimate, BIAF beat 1, missed 7 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $1.07M, down 26.2% from $1.45M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$3.94N/AN/AN/AN/AN/AN/AN/ANov 6, 2026$1.07M
    Jun 30, 2026-$0.64N/AN/AN/AN/AN/AN/AN/AAug 7, 2026$1.51M
    Mar 31, 2026-$0.81N/AN/AN/AN/AN/AN/AN/AMay 8, 2026$1.35M
    Dec 31, 2025-$10.46N/AN/AN/AN/AN/AN/AN/AMar 13, 2026$1.59M
    Sep 30, 2025-$4.74-$2.70-$2.70 - -$2.70-75.56%MissN/A10 up, 1 downNov 14, 2025$1.45M
    Jun 30, 2025-$0.17-$0.10-$0.10 - -$0.10-70.00%MissN/A11 up, 0 downAug 14, 2025$1.27M
    Mar 31, 2025-$0.16-$0.17N/A+5.88%BeatN/A11 up, 0 downMay 15, 2025$1.85M
    Dec 31, 2024-$0.19-$0.14-$0.14 - -$0.14-35.71%MissN/A10 up, 0 downMar 31, 2025$2.21M
    Sep 30, 2024-$0.16-$0.15-$0.15 - -$0.15-6.67%MissN/A10 up, 0 downNov 14, 2024$2.35M
    Jun 30, 2024-$0.19-$0.17-$0.17 - -$0.17-11.76%MissN/A10 up, 0 downAug 14, 2024$2.40M
    Mar 31, 2024-$0.26-$0.20N/A-28.35%MissN/AN/AN/AApr 1, 2024$2.41M
    Dec 31, 2023Not reported-$0.20N/AN/ANot reportedN/AN/AN/AMar 5, 2024$2.21M
    Sep 30, 2023-$0.26-$0.15N/A-73.33%MissN/AN/AN/ANov 14, 2023$298484
    Jun 30, 2023-$0.20-$0.20N/A0.00%In lineN/AN/AN/AAug 14, 2023$19738
    Mar 31, 2023-$0.18-$0.18N/A0.00%In lineN/AN/AN/AMay 15, 2023$921
    Dec 31, 2022-$0.19-$0.19N/A0.00%In lineN/AN/AN/AMar 31, 2023$2346
    Sep 30, 2022-$1.17-$1.17N/A0.00%In lineN/AN/AN/ANov 14, 2022$1150
    Jun 30, 2022-$0.03N/AN/AN/AN/AN/AN/AN/ASep 2, 2022$1306
    Mar 31, 2022-$0.48N/AN/AN/AN/AN/AN/AN/AJun 16, 2022N/A
    Last 19 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$15.53, after -$0.80 the year before. It was -$1.87 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$15.53N/A
    Dec 31, 2024-$0.80N/A
    Dec 31, 2023-$0.64N/A
    Dec 31, 2022-$1.87N/A

    Frequently Asked Questions About BIAF

    When is bioAffinity Technologies's next earnings date?

    bioAffinity Technologies's next earnings report is expected for Mar 11, 2027.

    How often does BIAF beat earnings estimates?

    bioAffinity Technologies beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -36.94%.